Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
(5-hydroxy-6-methyl-4-{[(E)-(3-oxo-1,2-oxazolidin-4-ylidene)amino]methyl}-3-pyridinyl)methyl dihydrogen phosphate
- Development stage
- Unknown
- Modality
- Small Molecules
01
Overview
This compound is a small molecule belonging to the class of pyridoxamine 5'-phosphates, which are heterocyclic aromatic compounds containing a pyridoxamine moiety with a phosphate group at the 5'-position. It is an experimental drug candidate and has been referenced in chemical and pharmacological databases but does not have an established clinical use or approved indication. Its mechanism of action and therapeutic applications are not described in publicly available sources. The compound is also known by its code name PD124875[1][7][8].
- Other names
- (5-hydroxy-6-methyl-4-{[(E)-(3-oxo-1,2-oxazolidin-4-ylidene)amino]methyl}-3-pyridinyl)methyl dihydrogen phosphate[5-hydroxy-6-methyl-4-( {[(4E)-3 -oxo -1,2 -oxazolidin -4 -ylidene ]amino }methyl )pyridin -3 -yl ]methyl dihydrogen phosphate{[5-hydroxy -6-methyl -4 -( {[( 4E )– 3 – oxo – 1 , 2 – oxazolidin – 4 – ylidene ] amino } methyl ) pyridin– 3– yl ] methyl} phosphonic acidPD124875PD-124875PD 124875
Beyond the preview
Go deeper on (5-hydroxy-6-methyl-4-{[(E)-(3-oxo-1,2-oxazolidin-4-ylidene)amino]methyl}-3-pyridinyl)methyl dihydrogen phosphate.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on (5-hydroxy-6-methyl-4-{[(E)-(3-oxo-1,2-oxazolidin-4-ylidene)amino]methyl}-3-pyridinyl)methyl dihydrogen phosphate.